August 8, 2026 · Gynecologic oncology reports · DOI: 10.1016/j.gore.2026.102173

Interval debulking with HIPEC in patient with VP shunt

Listen to this summary

The authors investigate the safety and feasibility of administering hyperthermic intraperitoneal chemotherapy (HIPEC) in a patient with an indwelling ventriculoperitoneal (VP) shunt, a scenario previously unreported in the literature. They present a case where a multidisciplinary approach allowed for successful interval debulking surgery with HIPEC, demonstrating that this treatment can be safely performed without complications in such patients. This finding suggests that HIPEC may be a viable option for ovarian cancer patients with VP shunts, potentially expanding their treatment possibilities.

R Shanoada, J Stephens, Z R Al-Wahab

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play